The Medical Letter on Drugs and Therapeutics
Benzyl Alcohol Lotion for Head Lice
The full article is available to subscribers Subscriber Login   
Revised 8/5/09: In Table 1, the price for lindane 1% shampoo should have been $136.86 (not $3.00).

The FDA has approved benzyl alcohol lotion, 5% (Ulesfia Lotion – Sciele) for treatment of head lice in patients ≥6 months old. The active ingredient is 5% benzyl alcohol; the vehicle is 5% mineral oil.

MECHANISM OF ACTION — Lice exposed to benzyl alcohol lose the ability to close their respiratory spiracles; the lotion vehicle then obstructs their airways and causes them to asphyxiate. Benzyl alcohol has no ovicidal activity.

CLINICAL STUDIES — In 2 unpublished, randomized, double-blind, vehicle-controlled clinical trials (described in the package insert), a total of 250 patients ≥6 months old with head lice received two 10-minute applications of the active treatment applied one week apart. Benzyl alcohol eliminated all live lice in 76.2% and 75% of patients examined 14 days after the final treatment, compared to 4.8% and 26.2% with the vehicle alone. Resistance to the drug has not ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Benzyl Alcohol Lotion for Head Lice
Article code: 1317b
 Electronic, downloadable article - $25